Shortsell.net [Beta]

Co-Diagnostics

CODX

EKF Diagnostics (Entwicklung, Konstruktion und Fertigung) is a publicly listed Healthcare company founded 1990 in Barleben, Germany and is currently headquartered in Cardiff, Wales, UK. EKF Diagnostics specialises in the development, manufacture and distribution of point of care analysers for hemoglobin, HbA1c, glucose, lactate as well as a range of clinical chemistry products and biomarker-based ELISA & rapid tests, a result of EKF Diagnostics' acquisition of Stanbio and Argutus Medical. EKF Diagnostics has nine sites in six countries and employs 295 people as of 31 December 2011.

Co-Diagnostics has been a target of short sellers for a while. The current short interest of 9.34% is slightly above the average of the last 12 months (3.69%).

Short Interest Trend
Total NSP
9.34%
+3.10%
vs. last month
Note: The short selling data for Co-Diagnostics may be distorted by a recent stock split!